NASDAQ : AVTX
Avalo Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 7.44 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 399.01M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Avalo Therapeutics, Inc. (AVTX) reported revenue of 59.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 59.00K | 59.00K | 441.00K | 1.92M | 18.05M | 5.40M |
| Cost of Revenue | 47.95M | 35.35M | 15.28M | 9.95M | 25.99M | 50.12M |
| Gross Profit | -47.89M | -35.29M | -14.84M | -8.02M | -7.94M | -44.72M |
| Selling, General & Admin | 27.06M | 22.90M | 17.24M | 10.30M | 13.91M | 24.66M |
| Research & Development | 16.40M | 14.74M | 8.79M | 5.12M | 8.05M | 11.21M |
| Amortization of Goodwill & Intangibles | 38.00K | 1.55M | ||||
| Operating Expenses | 43.47M | 37.64M | 26.04M | 15.42M | 22.00M | 37.41M |
| Operating Income | -91.36M | -72.92M | -40.87M | -23.44M | -29.94M | -82.13M |
| Interest Expense | -3.42M | -4.17M | -2.39M | |||
| Interest & Investment Income | 5.67M | 4.35M | 3.31M | |||
| Other Non Operating Income (Expenses) | -14.47M | -9.52M | 30.18M | -762.00K | -20.00K | -20.00K |
| EBT Excluding Unusual Items | -100.16M | -78.09M | -7.37M | -27.62M | -34.13M | -84.55M |
| Merger & Restructuring Charges | -7.50M | |||||
| Impairment of Goodwill | -3.91M | |||||
| Pretax Income | -100.16M | -78.09M | -35.02M | -31.53M | -41.63M | -84.55M |
| Income Tax Expense | 170.00K | 165.00K | 114.00K | 14.00K | 28.00K | -196.00K |
| Earnings From Continuing Operations | -100.33M | -78.26M | -35.13M | -31.54M | -41.66M | -84.35M |
| Earnings From Discontinued Operations | -27.00K | |||||
| Net Income | -100.33M | -78.26M | -35.13M | -31.54M | -41.66M | -84.38M |
| Net Income to Common | -100.33M | -78.26M | -35.13M | -31.54M | -41.66M | -84.38M |
| Shares Outstanding (Basic) | 24.03M | 13.40M | 4.43M | 277.73K | 39.20K | 36.19K |
| Shares Outstanding (Diluted) | 24.03M | 13.40M | 7.50M | 277.73K | 39.20K | 36.19K |
| EPS (Basic) | -4.18 | -5.84 | -7.94 | -113.58 | -1,062.65 | -2,331.41 |
| EPS (Diluted) | -4.18 | -5.84 | -20.91 | -113.58 | -1,062.65 | -2,331.41 |
| Free Cash Flow | -68.29M | -51.46M | -49.06M | -30.84M | -26.85M | -71.00M |
| Free Cash Flow Per Share | -2.84 | -3.84 | -6.54 | -111.04 | -684.81 | -1,961.95 |
| Gross Margin | -43.98% | |||||
| Operating Margin | -154,847.46% | -123,601.69% | -9,267.80% | -1,218.50% | -165.86% | -1,521.56% |
| Profit Margin | -170,055.93% | -132,642.37% | -7,965.76% | -1,639.50% | -230.78% | -1,563.10% |
| Free Cash Flow Margin | -115,745.76% | -87,216.95% | -11,123.81% | -1,602.81% | -148.72% | -1,315.39% |
| EBITDA | -91.25M | -72.58M | -40.70M | -23.29M | -29.77M | -80.48M |
| EBITDA Margin | -164.94% | |||||
| D&A For EBITDA | 109.00K | 344.00K | 169.00K | 158.00K | 166.00K | 1.66M |
| EBIT | -91.36M | -72.92M | -40.87M | -23.44M | -29.94M | -82.13M |
| EBIT Margin | -165.86% | |||||
| Revenue as Reported | 59.00K | 59.00K | 441.00K | 1.92M | 18.05M | 5.40M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 85.38M | 15.86M | 134.55M | 7.42M | 13.17M | 54.59M |
| Short-Term Investments | 314.89M | 82.48M | ||||
| Cash & Short-Term Investments | 400.28M | 98.34M | 134.55M | 7.42M | 13.17M | 54.59M |
| Accounts Receivable | 1.06M | |||||
| Other Receivables | 136.00K | 1.92M | 3.74M | |||
| Receivables | 136.00K | 1.92M | 4.80M | |||
| Inventory | 20.00K | 38.00K | ||||
| Prepaid Expenses | 7.61M | 6.91M | 4.33M | 843.00K | 1.29M | 2.37M |
| Restricted Cash | 49.00K | 37.00K | 19.00K | 1.00K | 15.00K | 51.00K |
| Total Current Assets | 407.93M | 105.29M | 138.89M | 8.39M | 16.42M | 61.84M |
| Property, Plant & Equipment | 288.00K | 460.00K | 1.21M | 1.97M | 2.41M | 2.69M |
| Goodwill | 10.50M | 10.50M | 10.50M | 10.50M | 14.41M | 14.41M |
| Other Intangible Assets | 38.00K | |||||
| Other Long-Term Assets | 183.00K | 210.00K | 131.00K | 131.00K | 131.00K | 1.23M |
| Total Assets | 490.78M | 116.46M | 150.73M | 20.99M | 33.37M | 80.21M |
| Accounts Payable | 3.35M | 137.00K | 283.00K | 446.00K | 2.88M | 3.37M |
| Accrued Expenses | 7.54M | 12.41M | 5.21M | 1.76M | 10.51M | 14.29M |
| Current Portion of Long-Term Debt | 5.93M | |||||
| Current Portion of Leases | 242.00K | 392.00K | 568.00K | 537.00K | 532.00K | 485.00K |
| Current Unearned Revenue | 88.00K | |||||
| Other Current Liabilities | 10.00M | 894.00K | 1.87M | 2.17M | 1.74M | |
| Total Current Liabilities | 21.13M | 12.94M | 6.96M | 4.62M | 22.11M | 19.89M |
| Long-Term Debt | 13.49M | 32.83M | ||||
| Long-Term Leases | 35.00K | 350.00K | 1.37M | 1.71M | 2.02M | |
| Long-Term Deferred Tax Liabilities | 463.00K | 434.00K | 270.00K | 155.00K | 141.00K | 113.00K |
| Other Long-Term Liabilities | 20.53M | 20.00M | 10.12M | 7.55M | 6.83M | 2.28M |
| Total Liabilities | 42.12M | 33.41M | 17.70M | 13.69M | 44.28M | 57.13M |
| Common Stock | 53.00K | 18.00K | 10.00K | 1.00K | 9.00K | |
| Additional Paid-In Capital | 953.70M | 531.49M | 503.29M | 342.44M | 292.91M | 285.24M |
| Retained Earnings | -504.51M | -448.52M | -370.26M | -335.13M | -303.82M | -262.17M |
| Comprehensive Income & Other | -583.00K | 68.00K | ||||
| Shareholders' Equity | 448.66M | 83.05M | 133.03M | 7.30M | -10.91M | 23.08M |
| Total Liabilities & Equity | 490.78M | 116.46M | 150.73M | 20.99M | 33.37M | 80.21M |
| Total Debt | 242.00K | 427.00K | 918.00K | 1.90M | 21.66M | 35.34M |
| Net Cash (Debt) | 400.03M | 97.91M | 133.63M | 5.51M | -8.49M | 19.25M |
| Net Cash Per Share | 16.65 | 7.30 | 17.83 | 19.85 | -216.49 | 531.87 |
| Filing Date Shares Outstanding | 53.63M | 22.79M | 10.67M | 1.03M | 55.00K | 39.16K |
| Total Common Shares Outstanding | 52.90M | 18.51M | 10.47M | 801.75K | 39.29K | 39.16K |
| Working Capital | 386.80M | 92.35M | 131.93M | 3.78M | -5.70M | 41.96M |
| Book Value Per Share | 8.48 | 4.49 | 12.70 | 9.11 | -277.78 | 589.35 |
| Tangible Book Value | 438.16M | 72.55M | 122.53M | -3.20M | -25.32M | 8.63M |
| Tangible Book Value Per Share | 8.28 | 3.92 | 11.70 | -3.99 | -644.47 | 220.48 |
| Machinery | 138.00K | 282.00K | 282.00K | 336.00K | 241.00K | |
| Leasehold Improvements | 239.00K | 896.00K | 896.00K | 739.00K | 739.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -100.33M | -78.26M | -35.13M | -31.54M | -41.66M | -84.38M |
| Depreciation & Amortization | 109.00K | 344.00K | 169.00K | 158.00K | 166.00K | 1.66M |
| Other Amortization | 1.83M | 1.39M | 794.00K | |||
| Asset Writedown & Restructuring Costs | 27.64M | 3.91M | ||||
| Loss (Gain) From Sale of Investments | -1.07M | -690.00K | ||||
| Stock-Based Compensation | 16.54M | 13.62M | 5.85M | 3.48M | 7.55M | 8.17M |
| Other Operating Activities | 9.83M | 9.69M | -42.88M | 734.00K | 5.86M | 22.00K |
| Change in Accounts Receivable | 1.06M | 1.12M | ||||
| Change in Inventory | 20.00K | 18.00K | -35.00K | |||
| Change in Accounts Payable | 981.00K | -146.00K | -163.00K | -2.44M | -487.00K | 796.00K |
| Change in Unearned Revenue | -88.00K | 88.00K | ||||
| Change in Other Net Operating Assets | 5.65M | 3.99M | -4.54M | -6.74M | -739.00K | 961.00K |
| Operating Cash Flow | -68.29M | -51.46M | -49.06M | -30.68M | -26.75M | -70.89M |
| Capital Expenditures | -158.00K | -95.00K | -113.00K | |||
| Sale of Property, Plant & Equipment | 25.00K | |||||
| Cash Acquisitions | 356.00K | |||||
| Investment in Securities | -315.28M | -81.72M | ||||
| Investing Cash Flow | -315.28M | -81.72M | 356.00K | -133.00K | -95.00K | -113.00K |
| Long-Term Debt Issued | 32.90M | |||||
| Long-Term Debt Repaid | -21.24M | -14.81M | ||||
| Net Debt Issued (Repaid) | -21.24M | -14.81M | 32.90M | |||
| Issuance of Common Stock | 454.31M | 15.56M | 185.07M | 46.29M | 107.00K | 73.86M |
| Repurchase of Common Stock | -780.00K | -510.00K | ||||
| Other Financing Activities | -26.86M | -462.00K | -9.22M | |||
| Financing Cash Flow | 426.66M | 14.59M | 175.85M | 25.04M | -14.70M | 106.76M |
| Net Cash Flow | 43.09M | -118.59M | 127.15M | -5.77M | -41.55M | 35.76M |
| Free Cash Flow | -68.29M | -51.46M | -49.06M | -30.84M | -26.85M | -71.00M |
| Free Cash Flow Margin | -115,745.76% | -87,216.95% | -11,123.81% | -1,602.81% | -148.72% | -1,315.39% |
| Free Cash Flow Per Share | -2.84 | -3.84 | -6.54 | -111.04 | -684.81 | -1,961.95 |
| Levered Free Cash Flow | -23.27M | -17.26M | -16.08M | -17.49M | -12.04M | -37.89M |
| Unlevered Free Cash Flow | -23.27M | -17.26M | -16.08M | -17.18M | -10.82M | -37.19M |
| Cash Interest Paid | 1.93M | 2.93M | 1.58M | |||
| Change in Working Capital | 6.63M | 3.84M | -4.71M | -9.24M | -60.00K | 2.84M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 384.53M | 329.31M | 77.74M | 7.29M | 47.45M | 190.94M |
| Enterprise Value | -15.51M | 218.25M | -822.21K | -893.45K | 51.89M | 153.11M |
| Last Close Price | 7.17 | 18.16 | 7.43 | 9.10 | 1,209.61 | 4,895.96 |
| PS Ratio | 6,517.41 | 5,581.57 | 176.29 | 3.79 | 2.63 | 35.37 |
| PB Ratio | 0.85 | 3.96 | 0.58 | 1.00 | -4.35 | 8.27 |
| P/TBV Ratio | 0.88 | 4.54 | 0.63 | 22.11 | ||
| EV/Sales Ratio | 3,699.17 | 2.87 | 28.36 | |||
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | 0.26 | -1.98 | 1.53 |
| Net Debt / Equity Ratio | -0.89 | -1.18 | -1.00 | -0.76 | -0.78 | -0.83 |
| Net Debt / EBITDA Ratio | 4.38 | 1.35 | 3.28 | 0.24 | -0.28 | 0.24 |
| Net Debt / FCF Ratio | 5.86 | 1.90 | 2.72 | 0.18 | -0.32 | 0.27 |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.07 | 0.32 | 0.09 |
| Inventory Turnover | 896.21 | 2,444.83 | ||||
| Quick Ratio | 18.94 | 7.60 | 19.33 | 1.64 | 0.68 | 2.99 |
| Current Ratio | 19.31 | 8.14 | 19.95 | 1.82 | 0.74 | 3.11 |
| Return on Equity (ROE) | -36.27% | -72.44% | -50.06% | -684.77% | -354.08% | |
| Return on Assets (ROA) | -18.50% | -34.12% | -29.75% | -53.91% | -32.95% | -82.82% |
| Return on Invested Capital (ROIC) | -187.88% | -359.43% | -396.92% | -1,501.54% | ||
| Return on Capital Employed (ROCE) | -19.50% | -70.40% | -28.40% | -143.20% | -266.10% | -136.20% |
| Earnings Yield | -58.24% | -23.76% | -45.18% | -432.43% | -87.80% | -44.19% |
| FCF Yield | -17.76% | -15.63% | -63.10% | -422.75% | -56.58% | -37.19% |
| Buyback Yield / Dilution | -158.89% | -78.82% | -2,599.19% | -608.45% | -8.32% | -41.86% |